Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Net Income (2016 - 2025)

Historic Net Income for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$139748.0.

  • Immucell's Net Income rose 8008.41% to -$139748.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 16097.25%. This contributed to the annual value of -$2.2 million for FY2024, which is 6265.32% up from last year.
  • Per Immucell's latest filing, its Net Income stood at -$139748.0 for Q3 2025, which was up 8008.41% from $501880.0 recorded in Q2 2025.
  • Immucell's Net Income's 5-year high stood at $1.4 million during Q1 2025, with a 5-year trough of -$2.3 million in Q1 2023.
  • In the last 5 years, Immucell's Net Income had a median value of -$441303.0 in 2021 and averaged -$457589.9.
  • Per our database at Business Quant, Immucell's Net Income crashed by 234979.9% in 2022 and then surged by 43046.1% in 2025.
  • Over the past 5 years, Immucell's Net Income (Quarter) stood at $74134.0 in 2021, then tumbled by 2349.8% to -$1.7 million in 2022, then soared by 31.66% to -$1.1 million in 2023, then surged by 145.14% to $514555.0 in 2024, then crashed by 127.16% to -$139748.0 in 2025.
  • Its last three reported values are -$139748.0 in Q3 2025, $501880.0 for Q2 2025, and $1.4 million during Q1 2025.